NIH ends funding of research that uses human fetal tissue from abortions

AI Summary
The National Institutes of Health (NIH) has ceased funding research using human fetal tissue obtained from elective abortions, effective immediately. This reverses a policy implemented by President Biden in 2021 and reinstates a ban initially put in place during the Trump administration. The NIH director stated the decision aims to modernize the agency by investing in alternative technologies for modeling human health and disease. While research using fetal tissue from miscarriages is still permitted, scientists often prefer tissue from elective abortions due to its higher quality and availability. In fiscal year 2024, the NIH directed almost $60 million to 77 projects involving fetal tissue from abortions, which has been used in research for diseases like diabetes and in the development of vaccines.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis.
Topic Connections
Explore how the topics in this article connect to other news stories
Find Similar Articles
AI-PoweredDiscover articles with similar content using semantic similarity analysis.